(IBGA) iShares iBonds Dec 2044 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Target Maturity
IBGA: Publicly-Issued U.S. Treasury Securities, Mature 2044, Government Debt
The iShares iBonds Dec 2044 Term Treasury ETF (IBGA) is designed to provide exposure to U.S. Treasury securities maturing between January 1, 2044, and December 15, 2044. This target maturity ETF typically appeals to investors seeking predictable returns and reduced reinvestment risk as the maturity date approaches. The fund employs a passive management strategy, aiming to replicate the performance of its underlying index by holding securities that meet specific criteria. This approach allows for a straightforward way to gain exposure to a defined segment of the Treasury market.
From a technical perspective, IBGA has shown a price of $25.21 with a 20-day average volume of 30,353 shares, indicating moderate liquidity. The short-term trend, as indicated by the 20-day SMA of $24.93, suggests recent strength above the longer-term 50-day SMA of $24.48. The 200-day SMA of $25.10 is slightly above the current price, signaling potential support at these levels. The ATR of 0.19 reflects low volatility, typical for Treasury-focused ETFs. Over the next three months, IBGA is expected to maintain stability, potentially trending upward if interest rates remain stable. The AUM of $54.95M suggests a moderate fund size, which is sufficient for most investors seeking targeted Treasury exposure.
Additional Sources for IBGA ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBGA ETF Overview
Market Cap in USD | 55m |
Category | Target Maturity |
TER | 0.07% |
IPO / Inception | 2024-06-11 |
IBGA ETF Ratings
Growth 5y | -3.48% |
Fundamental | - |
Dividend | 27.0% |
Rel. Strength Industry | 3.52 |
Analysts | - |
Fair Price Momentum | 23.82 USD |
Fair Price DCF | - |
IBGA Dividends
Dividend Yield 12m | 2.34% |
Yield on Cost 5y | 2.39% |
Annual Growth 5y | -56.61% |
Payout Consistency | 100.0% |
IBGA Growth Ratios
Growth Correlation 3m | 56.2% |
Growth Correlation 12m | -31% |
Growth Correlation 5y | -31% |
CAGR 5y | 2.73% |
CAGR/Max DD 5y | 0.23 |
Sharpe Ratio 12m | 0.01 |
Alpha | -2.01 |
Beta | 0.13 |
Volatility | 11.07% |
Current Volume | 2k |
Average Volume 20d | 5.4k |
As of March 14, 2025, the stock is trading at USD 25.20 with a total of 2,000 shares traded.
Over the past week, the price has changed by +0.33%, over one month by +2.42%, over three months by +1.99% and over the past year by +2.73%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2044 is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.48 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBGA as of March 2025 is 23.82. This means that IBGA is currently overvalued and has a potential downside of -5.48%.
iShares iBonds Dec 2044 has no consensus analysts rating.
According to ValueRays Forecast Model, IBGA iShares iBonds Dec 2044 will be worth about 25.7 in March 2026. The stock is currently trading at 25.20. This means that the stock has a potential upside of +2.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.7 | 2.1% |